Engineered E. coli shows promise in cancer immunotherapy

Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

Is Leadership Bias Holding Back Virtual Healthcare Adoption?

Andy Flanagan, CEO at Iris Telehealth Virtual healthcare has experienced a remarkable surge in recent years, with over 116 million users worldwide engaging in online

October 25, 2024

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

Once-weekly prophylaxis with efanesoctocog alfa (Altuviiio) led to high sustained factor VIII activity and was effective in preventing bleeding among children with severe hemophilia A,

July 18, 2024

Multidisciplinary approach improves quality of life in functional movement disorders

The research team of the Neurology Department Movement Disorders Unit at the Virgen del Rocío University Hospital and the Movement Disorders group of the Institute

October 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.